Related Experiment Videos
[The male climacteric. A responsibility for dermatologic andrology?]
1Abteilung Andrologie, Klinikum der Philipps-Universität Marburg.
Summary
Male sexual impotence, a key symptom of male climacteric, is linked to aging and disease impacting testosterone levels. Sexual function decline in aging men may not directly correlate with testosterone reduction.
Area of Science:
- Endocrinology
- Andrology
- Gerontology
Context:
- The male climacteric, analogous to female menopause, presents with sexual impotence as a primary symptom.
- Unlike female menopause, male climacteric lacks established treatment institutions.
- Testosterone production declines with age, influenced by disease in aging men.
Purpose:
- To investigate the relationship between aging, disease, and testosterone levels in men.
- To analyze the Massachusetts Male Aging Study data on hormone levels and age.
- To explore the endocrine basis of the male climacteric and associated sexual dysfunction.
Summary:
- The Massachusetts Male Aging Study found mean testosterone levels decrease by 1% and free testosterone by 1.2% annually.
- Disease significantly impacts testosterone decline in aging men more than age alone.
- Sexual dysfunction frequency increases with age, partly due to drug interactions.
Impact:
- Findings inform potential hormone substitution recommendations for aging men.
- Highlights the need to explore non-endocrine factors for the male climacteric and mid-life crisis.
- Emphasizes the distinction between age-related testosterone decline and sexual function in aging males.